Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

23  +0.46 (+2.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 50 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.30%, 1BAYN is doing worse than 62.00% of the companies in the same industry.
With a Return On Equity value of -8.00%, 1BAYN is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.3%
ROE -8%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
With a Gross Margin value of 54.36%, 1BAYN is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1BAYN has declined.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.36%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1BAYN remains at a similar level compared to 1 year ago.
1BAYN has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for 1BAYN has been reduced compared to a year ago.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.79, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.79, 1BAYN is doing worse than 62.00% of the companies in the same industry.
The Debt to FCF ratio of 1BAYN is 8.90, which is on the high side as it means it would take 1BAYN, 8.90 years of fcf income to pay off all of its debts.
1BAYN has a Debt to FCF ratio (8.90) which is in line with its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that 1BAYN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.11, 1BAYN is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.9
Altman-Z 0.79
ROIC/WACCN/A
WACC6.17%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1BAYN has a Current Ratio of 1.19. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
1BAYN's Current ratio of 1.19 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 64.00% of its industry peers.
A Quick Ratio of 0.72 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN has a worse Quick ratio (0.72) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.72
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.09%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -2.16%.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-21.09%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-43.24%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-1.12%

3.2 Future

The Earnings Per Share is expected to grow by 1.19% on average over the next years.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.18% yearly.
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue Next Year0.12%
Revenue Next 2Y0.98%
Revenue Next 3Y1.38%
Revenue Next 5Y1.18%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.55 indicates a rather cheap valuation of 1BAYN.
96.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
1BAYN is valuated cheaply when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 4.99.
Based on the Price/Forward Earnings ratio, 1BAYN is valued cheaply inside the industry as 98.00% of the companies are valued more expensively.
1BAYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.55
Fwd PE 4.99
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1BAYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 88.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 98.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.92
EV/EBITDA 6
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.15%
EPS Next 3Y1.51%

More info and screens

1

5. Dividend

5.1 Amount

1BAYN has a yearly dividend return of 0.52%, which is pretty low.
Compared to an average industry Dividend Yield of 3.15, 1BAYN has a dividend in line with its industry peers.
With a Dividend Yield of 0.52, 1BAYN pays less dividend than the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-5.13%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (4/25/2025, 7:00:00 PM)

23

+0.46 (+2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05 2025-03-05/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners47.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.60B
Analysts67.59
Price Target27.61 (20.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-5.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.93%
Min EPS beat(2)-17.26%
Max EPS beat(2)3.41%
EPS beat(4)3
Avg EPS beat(4)0.78%
Min EPS beat(4)-17.26%
Max EPS beat(4)12.55%
EPS beat(8)5
Avg EPS beat(8)-3.08%
EPS beat(12)8
Avg EPS beat(12)-0.96%
EPS beat(16)12
Avg EPS beat(16)2.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-3.42%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-4%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-2.97%
Revenue beat(12)5
Avg Revenue beat(12)-1.57%
Revenue beat(16)9
Avg Revenue beat(16)-0.6%
PT rev (1m)-0.59%
PT rev (3m)-1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.84%
EPS NY rev (1m)-2.05%
EPS NY rev (3m)-15.04%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-3.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 4.55
Fwd PE 4.99
P/S 0.48
P/FCF 4.92
P/OCF 3.07
P/B 0.71
P/tB N/A
EV/EBITDA 6
EPS(TTM)5.05
EY21.96%
EPS(NY)4.61
Fwd EY20.06%
FCF(TTM)4.67
FCFY20.3%
OCF(TTM)7.5
OCFY32.6%
SpS47.44
BVpS32.48
TBVpS-20.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.3%
ROE -8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.36%
FCFM 9.84%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 8.9
Debt/EBITDA 4.07
Cap/Depr 31.63%
Cap/Sales 5.96%
Interest Coverage N/A
Cash Conversion 84.55%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.72
Altman-Z 0.79
F-Score6
WACC6.17%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.09%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-43.24%
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y1.19%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-1.12%
Revenue Next Year0.12%
Revenue Next 2Y0.98%
Revenue Next 3Y1.38%
Revenue Next 5Y1.18%
EBIT growth 1Y-111.6%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year66.19%
EBIT Next 3Y20.82%
EBIT Next 5Y9.38%
FCF growth 1Y93.91%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y43.95%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%